Endocrinol Metab. 1993;76:309-317.
Bennett R Growth hormone in musculoskeletal pain states.Curr Rheumatol Rep. 2004 Aug; 6(4):266-73.
Bennett RM et al. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia Am J Med. 1998 Mar; 104(3):227-31.
Besson A et al. Reduced longevity in untreated patients with isolated growth hormone deficiency. J Clin Endocrinol Metab. 2003 Aug; 88(8):3664-7.
Biller BM et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab. 2002 May; 87(5):2067-79.
Blackman M et al. Growth Hormone and Sex Steroid Administration in Healthy Aged Women and Men. JAMA November 13, 2002. Vol 288 No 18.
Bocchi EA et al. Growth hormone for optimization of refractory heart failure treatment. Arq Bras Cardiol 1999 Oct; 73(4):391-8
Bogarin R et al. Growth hormone treatment and risk of recurrence or progression of brain tumors in children: a review. Childs Nerv Syst. 2009 Jan 14
Boguszewski CL, Meister LH, Zaninelli DC, Radominski RB. One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults. Eur J Endocrinol. 2005;152:67-75.
Bohdanowicz-Pawlak A et al. Risk factors of cardiovascular disease in GH-deficient adults with hypopituitarism: a preliminary report. Med Sci Monit. 2006 Feb; 12(2):CR75-80.
Borson-Chazot F. et al. Decrease in Carotid Intima-Media Thickness after One Year Growth Hormone (GH) Treatment in Adults with GH Deficiency J Clin Endocrinol Metab 84: 1329–1333, 1999
Branski LK et al. Randomized Controlled Trial to Determine the Efficacy of Long-Term Growth Hormone Treatment in Severely Burned Children., Ann Surg. 2009 Sep 2
Burgess W et al. The immune-endocrine loop during aging: role of growth hormone and insulin-like growth factor-I. Neuroimmunomodulation 1999 Jan-Apr; 6(1-2):56-68
Caidahl K, Edén S, Bengtsson BA. Cardiovascular and renal effects of growth hormone. Clin Endocrinol (Oxf). 1994;40:393-400.
Cappola AR et al. Association of IGF-I levels with muscle strength and mobility in older women. J Clin Endocrinol Metab 2001 Sep; 86(9):4139-46
Cappola et al. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women JCEM, 2003 May; 88(5):2019-25.
Cenci MC, Soares DV, Spina LD, Brasil RR, Lobo PM, Michmacher E, Vaisman M, Boguszewski CL, Conceição FL. Comparison of two dose regimens of growth hormone (GH) with different target IGF-1 levels on glucose metabolism, lipid profile, cardiovascular function and anthropometric parameters in gh-deficient adults. Growth Horm IGF Res. 2012;22:116-121.
Chan et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science Vol 279 January 1998
Cherbonnier C et al. Potentiation of tumour apoptosis by human growth hormone via glutathione production and decreased NF-kappaB activity. Br J Cancer. 2003 Sep 15;89(6):1108-15
Christiansen, J. Influence of growth hormone and androgens on body composition in adults. Horm Res. 1996; 45(1-2):94-8
Colao A et al. Beginning to end: Cardiovascular implications of growth hormone (GH) deficiency and GH therapy. Growth Horm IGF Res. 2006 May 9
Colao A et al. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly. J Clin Endocrinol Metab 1999 Jun; 84(6):1986-91
Colao A et al. Impaired cardiac performance in elderly patients with growth hormone deficiency J Clin Endocrinol Metab 1999 Nov; 84(11):3950-5
Colao A, di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab. 2001;86:1874-1881.
Colao A.Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 1999 Jun; 84(6):1919-24
Collier SR et al. Growth hormone responses to varying doses of oral arginine.Growth Horm IGF Res. 2005 Apr; 15(2):136-9.
Cook DM.Shouldn't adults with growth hormone deficiency be offered growth hormone replacement therapy?Ann Intern Med 2002 Aug 6;137(3):197-201
Cook, D et al. Route of Estrogen Administration Helps to Determine Growth Hormone (GH) Replacement Dose in GH-Deficient Adults. J Clin Endocrinol Metab 1999Nov; 84: (11): 3956–3960,
Corpas E et al. Oral arginine-lysine does not increase growth hormone or insulin-like growth factor-I in old men. J Gerontol 1993 Jul; 48(4):M128-33
Cuatrecasas G et al. Growth hormone as concomitant treatment in severe fibromyalgia associated with low IGF-1 serum levels. BMC Musculoskelet Disord. 2007 Nov 30:
Cuatrecasas G, Alegre C, Fernandez-Solà J, Gonzalez MJ, Garcia-Fructuoso F, Poca-Dias V, Nadal A, Cuatrecasas G, Navarro F, Mera A, Lage M, Peinó R, Casanueva F, Liñan C, Sesmilo G, Coves MJ, Izquierdo JP, Alvarez I, Granados E, Puig-Domingo M. Growth hormone treatment for sustained pain reduction and improvement in quality of life in severe fibromyalgia. Pain. 2012 Jul;153(7):1382-9.
Drake W et al Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 1998 Nov; 83(11):3913-9 Fazio et al. A preliminary study of GH in the treatment of dilated cardiomyopathy. NEJM 1996:334:809-814
Elbornsson M, Götherström G, Franco C, Bengtsson BÅ, Johannsson G, Svensson J. Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency. Eur J Endocrinol. 2012 Feb;166(2):181-9.
Fiebig HH et al. No evidence of tumor growth stimulation in human tumors in vitro following treatment with recombinant human growth hormone Anticancer Drugs 2000 Sep;11(8):659-64
Follin C, Thilén U, Ahrén B, Erfurth EM. Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2006 May;91(5):1872-5.
Franco C et al. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J Clin Endocrinol Metab. 2005 Mar; 90(3):1466-74
Franco C, Andersson B, Lönn L, Bengtsson BA, Svensson J, Johannsson G. Growth hormone reduces inflammation in postmenopausal women with abdominal obesity: a 12-month, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2007 Jul;92(7):2644-7.
French RA et al. Age-Associated Loss of Bone Marrow Hematopoietic Cells Is Reversed by GH and Accompanies Thymic Reconstitution Endocrinology Vol. 143, No. 2 690-699, Jan 2002
Frohman LA. Controversy about treatment of growth hormone-deficient adults: a commentary. Ann Intern Med. 2002 Aug 6;137(3):202-4.
Garten A, Schuster S, Kiess W. The insulin-like growth factors in adipogenesis and obesity. Endocrinol Metab Clin North Am. 2012 Jun;41(2):283-95,
